Bigul

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of the earnings conference call for the quarter ended December 31, 2023.
21-02-2024
Bigul

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith copies of newspaper publication.
15-02-2024
Bigul

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Con-call audio recording held to discuss Q3 FY24 Unaudited Financial Results.
14-02-2024
Bigul

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Change in Directorate

Appointment of Mr. M Mohan as Executive Director of the Company with effect from February 14, 2024.
14-02-2024
Bigul

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

Resignation of Mr. P V Raghavendra Rao from the position of Chief Financial Officer of the Company from the close of business hours of February 15, 2024.
14-02-2024
Bigul

Solara Active Pharma Sciences Ltd - 541540 - Unaudited Financial Results For The Period Ended December 31, 2023.

Unaudited Financial Results for the period ended December 31, 2023
14-02-2024
Bigul

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Investor call to discuss unaudited Fianacial results for the period ended December 31, 2023
05-02-2024
Next Page
Close

Let's Open Free Demat Account